These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9712097)

  • 1. Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor.
    Takemura H; Suzuki H; Fujisawa H; Yuhara T; Akama T; Yamane K; Kashiwagi H
    J Rheumatol; 1998 Aug; 25(8):1534-9. PubMed ID: 9712097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.
    Ludwicka A; Ohba T; Trojanowska M; Yamakage A; Strange C; Smith EA; Leroy EC; Sutherland S; Silver RM
    J Rheumatol; 1995 Oct; 22(10):1876-83. PubMed ID: 8991985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
    Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
    Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
    Kawaguchi Y; Harigai M; Hara M; Fukasawa C; Takagi K; Tanaka M; Tanaka E; Nishimagi E; Kamatani N
    J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PDGF, IL-1alpha, and BMP2/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea.
    Kim WJ; Mohan RR; Mohan RR; Wilson SE
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1364-72. PubMed ID: 10359318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast proliferation by bleomycin stimulated peripheral blood mononuclear cell factors.
    Yamamoto T; Katayama I; Nishioka K
    J Rheumatol; 1999 Mar; 26(3):609-15. PubMed ID: 10090171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts.
    Kawaguchi Y; McCarthy SA; Watkins SC; Wright TM
    J Rheumatol; 2004 Oct; 31(10):1946-54. PubMed ID: 15468358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor induction regulates the synergistic effects of substance P with IL-1 and platelet-derived growth factor on the proliferation of bone marrow fibroblasts.
    Rameshwar P; Poddar A; Zhu G; Gascón P
    J Immunol; 1997 Apr; 158(7):3417-24. PubMed ID: 9120302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast function in psoriatic arthritis. II. Increased expression of beta platelet derived growth factor receptors and increased production of growth factor and cytokines.
    Espinoza LR; Espinoza CG; Cuéllar ML; Scopelitis E; Silveira LH; Grotendorst GR
    J Rheumatol; 1994 Aug; 21(8):1507-11. PubMed ID: 7983655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obligatory action of polypeptide growth factors for the IL-1-mediated prostaglandin E2 production in fibroblasts. Potential role of growth factors in modulation of tissue response to IL-1.
    Chiou WJ; Bonin PD; Singh JP
    J Immunol; 1990 Oct; 145(7):2155-60. PubMed ID: 2144546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts.
    Kadono T; Kikuchi K; Ihn H; Takehara K; Tamaki K
    J Rheumatol; 1998 Feb; 25(2):296-301. PubMed ID: 9489822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor and inflammatory cytokines have differential effects on the expression of integrins alpha 1 beta 1 and alpha 5 beta 1 by human dermal fibroblasts in vitro.
    Gailit J; Xu J; Bueller H; Clark RA
    J Cell Physiol; 1996 Nov; 169(2):281-9. PubMed ID: 8908195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1 beta.
    Kawaguchi Y; Harigai M; Suzuki K; Hara M; Kobayashi K; Ishizuka T; Matsuki Y; Tanaka N; Nakamura H
    Biochem Biophys Res Commun; 1993 Jan; 190(1):154-61. PubMed ID: 8422241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
    Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
    Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased interleukin-17 production in patients with systemic sclerosis.
    Kurasawa K; Hirose K; Sano H; Endo H; Shinkai H; Nawata Y; Takabayashi K; Iwamoto I
    Arthritis Rheum; 2000 Nov; 43(11):2455-63. PubMed ID: 11083268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of human skin fibroblast chemotaxis to platelet-derived growth factor A-chain homodimer by transforming growth factor-beta1.
    Soma Y; Mizoguchi M; Yamane K; Yazawa N; Kubo M; Ihn H; Kikuchi K; Tamaki K
    Arch Dermatol Res; 2002 Feb; 293(12):609-13. PubMed ID: 11875643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.